![](\"https:\/\/mms.businesswire.com\/media\/20260803685764\/en\/2867179\/5\/ACTLAB_horiz_full_color.jpg\")
<\/a><\/a>\nNew Jersey represents an important milestone in ACT LAB\u2019s continued growth. As one of the nation\u2019s fastest-growing regulated cannabis markets, the state provides a significant opportunity to bring ACT LAB\u2019s best-in-class turnaround times and superior customer service to support operators, protect consumers, and strengthen confidence in regulated cannabis products.<\/p>
\n\u201cACT LAB\u2019s expansion in New Jersey builds on the strong customer relationships, local knowledge, and experienced team established by Sriven Labs, while adding the scientific depth and resources of one of the nation\u2019s largest and most experienced cannabis testing laboratory networks,\u201d said J. Michael Drozd, CEO of ACT LAB. \u201cIn addition to strengthening local testing capabilities, ACT LAB\u2019s national laboratory network provides meaningful value for both multistate operators and independent cannabis businesses who operate in New Jersey.\u201d<\/p>
\nACT LAB offers customers access to 100+ years of collective cannabis testing expertise, standardized analytical methods, and robust quality systems designed to deliver consistent, reliable results. The company\u2019s growing national footprint and harmonized testing methodologies protect brand integrity by providing greater consistency across markets. ACT LAB\u2019s customer data portal delivers centralized access to multistate testing data and provides trending tools to give customers the information they need to make faster, more informed business decisions.<\/p>
\n\u201cAs regulated cannabis markets continue to mature, high-quality and consistent laboratory services are increasingly important to helping operators reduce risk, improve consistency, and make better business decisions,\u201d said Austin Stevenson, Chief Revenue Officer at ACT LAB. \u201cOur investment in New Jersey reflects ACT LAB\u2019s commitment to being a long-term testing and compliance partner that supports operational excellence and delivers the resources operators need to succeed.\u201d<\/p>
\nThe New Jersey expansion builds on ACT LAB\u2019s continued investment in laboratory infrastructure across the United States. Over the past year, the company expanded its Pennsylvania operations with a second laboratory in Harrisburg, relocated and expanded its Ohio laboratory to Columbus to improve statewide service and turnaround times, and completed an expansion of its Illinois laboratory to increase testing capacity for operators. Together, these investments reflect ACT LAB\u2019s long-term strategy of building standardized laboratory operations that deliver consistent results across multiple markets.<\/p>
\n\u201cNew Jersey\u2019s regulated cannabis market is poised for continued growth,\u201d said Drozd. \u201cWe appreciate the New Jersey Cannabis Regulatory Commission\u2019s approval of this acquisition and look forward to partnering with both our customers and the CRC to give businesses and consumers confidence in the products on the dispensary shelf.\u201d<\/p>
\nCustomers will continue working through their existing local contacts, while gaining access to ACT LAB\u2019s broader scientific resources, standardized methodologies, and multistate laboratory network. The company remains committed to maintaining continuity of service while investing in additional laboratory capabilities that support New Jersey\u2019s regulated cannabis industry.<\/p>